Blog Full Width

AMCP Format for Formulary Dossiers Series – History of Actions by the FDA Governing Communication Between HCDMs and Manufacturers

One driver for the new AMCP format was the FDA Final Guidance, Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities, which allowed for communication of information on unapproved products and unapproved uses of approved products from manufacturers to payors, formulary committees, and

By |01/30/20|Categories: Post|0 Comments

DIA Pharmacovigilance and Risk Management Strategies Conference – January 27-29, 2020 in Washington, DC

Maria Anitan, Med Communication’s Global Head of Pharmacovigilance and Safety, will be attending the 3-day Pharmacovigilance and Risk Management Strategies Conference, January 27-29 in Washington, DC. With topics such as global regulatory updates from the FDA, EMA, and MHRA; expanding uses of real-world evidence for evidence

By |01/27/20|Categories: Post|1 Comment